Question 1

What is the catalog number for Tozasertib (VX-680, MK-0457, VX6)?

Accepted Answer

The catalog number for Tozasertib (VX-680, MK-0457, VX6) is 1595-25.

Question 2

Is Tozasertib (VX-680, MK-0457, VX6) in stock?

Accepted Answer

Tozasertib (VX-680, MK-0457, VX6) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is Tozasertib (VX-680, MK-0457, VX6) used for?

Accepted Answer

Tozasertib inhibits Aurora kinases A, B and C with Ki values of 0.6, 18 and 4.6 nM, respectively. It also inhibits Flt-3 and Abl as well as their mutant forms.

Question 4

Can this product be used for co-immunoprecipitation (Co-IP)?

Accepted Answer

Suitability for Co-IP depends on the specific antibody and is noted under validated applications on the datasheet. If it isn’t listed, contact our technical support team for guidance based on your target and sample type.

Question 5

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 6

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Tozasertib (VX-680, MK-0457, VX6)

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

MUC18 / Mucin 18 / CD146 (OJ79c), CF405S conjugate, 0.1mg/mL

CD11a (Cris-3), CF488A conjugate, 0.1mg/mL

CD28 (204.12), CF770 conjugate, 0.1mg/mL

CD5 (Cris-1), CF594 conjugate, 0.1mg/mL

CD63 (MX-49.129.5), CF647 conjugate, 0.1mg/mL

Mammaglobin (SCGB2A2) (Breast Cancer Marker) (MGB1/2000), CF640R conjugate, 0.1mg/mL